A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia

Clinical trial NCT07146386 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07146386
Sponsor: Shanghai Huilun Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms

Start date: 2025-08-01
Primary completion: 2027-01-01
Enrollment: 728

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.